News

Preparing for 2021: Drug and Device Pricing, Payment, and Fraud and Abuse Challenges

January 12, 2021
Arnold & Porter Webinar

There were a variety of important legal and regulatory developments in the final months of 2020 that will impact pharmaceutical manufacturers in 2021 and beyond. During this webinar, members of our Life Sciences & Healthcare Regulatory group review the following key developments in detail: value-based arrangements, manufacturer product support programs, manufacturer speaker programs, healthcare technology, CMS Medicaid Rebate Program final rule, and 340B Drug Pricing Program.

Meet the Speakers

Catherine A. Brandon
Partner
Arnold & Porter
John Gould
Partner
Arnold & Porter
Jeffrey L. Handwerker
Partner
Arnold & Porter
Kristin M. Hicks
Partner
Arnold & Porter
Ariane M. Horn
Partner
Arnold & Porter
Allison W. Shuren
Partner
Arnold & Porter
Matthew T. Fornataro
Counsel
Arnold & Porter
Rosemary Maxwell
Counsel
Arnold & Porter
Subscribe
Subscribe Link

Email Disclaimer